Vagus Nerve Stimulator

2022 ◽  
pp. 373-375
Author(s):  
John M. Stern ◽  
Noriko Salamon
2021 ◽  
Vol 71 ◽  
pp. 110193
Author(s):  
Arthur Chyan ◽  
Sangeeta Kumaraswami ◽  
Suryanarayana Pothula

2016 ◽  
Vol 30 ◽  
pp. 83-87 ◽  
Author(s):  
Sandi Lam ◽  
Yimo Lin ◽  
Daniel J. Curry ◽  
Gaddum D. Reddy ◽  
Peter C. Warnke

2009 ◽  
Vol 41 (5) ◽  
pp. 383-387 ◽  
Author(s):  
Naoaki Tanaka ◽  
Elizabeth A. Thiele ◽  
Joseph R. Madsen ◽  
Blaise F. Bourgeois ◽  
Steven M. Stufflebeam

2016 ◽  
Vol 11 (2) ◽  
pp. 151 ◽  
Author(s):  
Hinaesh Upadhyay ◽  
Sushanth Bhat ◽  
Divya Gupta ◽  
Martha Mulvey ◽  
Sue Ming

2012 ◽  
Vol 10 (3) ◽  
pp. 226-229 ◽  
Author(s):  
Will P. Rodgers ◽  
Andrew J. Durnford ◽  
Fenella J. Kirkham ◽  
Andrea Whitney ◽  
Mark A. Mullee ◽  
...  

Object Interrater reliability as measured by the kappa (κ) statistic is a widely used and valuable tool to measure the robustness of a scoring system. Seizure frequency reduction is a central outcome measure following vagus nerve stimulation (VNS). A specific VNS scoring system has been proposed by McHugh, but its interrater reliability has not been tested. The authors assessed its interrater reliability and compared it with that of the Engel and International League Against Epilepsy (ILAE) systems. Methods Using the Engel, ILAE, and McHugh scoring systems, 3 observers independently rated the medical records of children who had undergone vagus nerve stimulator implantation between January 2001 and April 2011 at the Southampton University Hospital. The interrater agreements were then calculated using the κ statistic. Results Interrater reliability for the McHugh scale (κ0.693) was very good and was superior to those of the Engel (κ0.464) and ILAE (κ0.491) systems for assessing outcome in patients undergoing VNS. Conclusions The authors recommend considering the McHugh scoring system when assessing outcomes following VNS.


Author(s):  
Christopher M. Carosella ◽  
David F. Smith ◽  
Kathleen M. Sarber ◽  
Michele Turner ◽  
Thomas J. Dye

AbstractVagus nerve stimulator (VNS)-associated sleep disordered breathing (SDB) is a poorly understood side effect of VNS treatment. We present a patient with VNS-associated SDB who underwent sleep laboratory VNS titration, evaluation by drug-induced sleep endoscopy, and treatment including adenotonsillectomy and positive airway pressure therapy. This case is unique as it is the first to document, in real time, the inverse correlation of VNS current with airflow. This case offers unique insights into mechanisms and treatment of VNS-associated SDB, and a novel approach in its management. Most importantly, this case highlights the need for collaboration between physicians managing epilepsy with VNS and those managing sleep.


2018 ◽  
Vol 22 (5) ◽  
pp. 630-637 ◽  
Author(s):  
Toni Kulju ◽  
Joonas Haapasalo ◽  
Sirpa Rainesalo ◽  
Kai Lehtimäki ◽  
Jukka Peltola

Sign in / Sign up

Export Citation Format

Share Document